Michael Jon  Brown net worth and biography

Michael Brown Biography and Net Worth

EVP of DexCom
Michael Brown is Executive Vice President and Chief Legal Officer at Dexcom, where he has worldwide responsibility for all legal and intellectual property matters.
Before joining Dexcom in 2022, Michael was a partner at DLA Piper, where he served as outside general counsel to companies, advised on important business and legal issues, assisted with corporate governance and executed mergers and acquisitions and financings. Prior to that, he was a partner at Stradling Yocca Carlson & Rauth, where he represented emerging and public technology, life science and other growth companies. Before that, Michael served as outside General Counsel for several high-growth companies.
Michael earned his J.D. from the University of Virginia School of Law and his B.A. from the University of Washington. Michael is a board member of Riding on Insulin, a non-profit organization that connects the global diabetes community through action sports.

What is Michael Jon Brown's net worth?

The estimated net worth of Michael Jon Brown is at least $5.00 million as of July 31st, 2024. Mr. Brown owns 66,249 shares of DexCom stock worth more than $5,003,787 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Brown may own. Additionally, Mr. Brown receives a salary of $1,220,000.00 as EVP at DexCom. Learn More about Michael Jon Brown's net worth.

How old is Michael Jon Brown?

Mr. Brown is currently 54 years old. There are 6 older executives and no younger executives at DexCom. The oldest executive at DexCom is Mr. Kevin Ronald Sayer, Executive Chairman, CEO & President, who is 66 years old. Learn More on Michael Jon Brown's age.

What is Michael Jon Brown's salary?

As the EVP of DexCom, Inc., Mr. Brown earns $1,220,000.00 per year. There are 3 executives that earn more than Mr. Brown. The highest earning executive at DexCom is Mr. Kevin Ronald Sayer, Executive Chairman, CEO & President, who commands a salary of $3,230,000.00 per year. Learn More on Michael Jon Brown's salary.

How do I contact Michael Jon Brown?

The corporate mailing address for Mr. Brown and other DexCom executives is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. DexCom can also be reached via phone at (858) 200-0200 and via email at [email protected]. Learn More on Michael Jon Brown's contact information.

Has Michael Jon Brown been buying or selling shares of DexCom?

Michael Jon Brown has not been actively trading shares of DexCom during the past quarter. Most recently, Michael Jon Brown sold 652 shares of the business's stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $69.55, for a transaction totalling $45,346.60. Following the completion of the sale, the executive vice president now directly owns 66,249 shares of the company's stock, valued at $4,607,617.95. Learn More on Michael Jon Brown's trading history.

Who are DexCom's active insiders?

DexCom's insider roster includes Donald Abbey (EVP), Steven Altman (Director), Nicholas Augustinos (Director), Andrew Balo (Insider), Quentin Blackford (COO), Michael Brown (EVP), Richard Collins (Director), Matthew Dolan (SVP), Richard Doubleday (EVP), Paul Flynn (EVP), Mark Foletta (Director), Bridgette Heller (Director), Barbara Kahn (Director), Jacob Leach (EVP), Jeffrey Moy (EVP), Patrick Murphy (EVP), Steven Pacelli (Insider), Chad Patterson (EVP), Barry Regan (EVP), Kevin Sayer (CEO), Shelly Selvaraj (SVP), Sumi Shrishrimal (SVP), Jay Skyler (Director), Sadie Stern (EVP), and Jereme Sylvain (CAO). Learn More on DexCom's active insiders.

Are insiders buying or selling shares of DexCom?

During the last twelve months, insiders at the medical device company sold shares 28 times. They sold a total of 252,409 shares worth more than $33,128,636.21. The most recent insider tranaction occured on September, 9th when EVP Sadie Stern sold 426 shares worth more than $29,457.90. Insiders at DexCom own 0.3% of the company. Learn More about insider trades at DexCom.

Information on this page was last updated on 9/9/2024.

Michael Jon Brown Insider Trading History at DexCom

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/31/2024Sell652$69.55$45,346.6066,249View SEC Filing Icon  
6/28/2024Sell659$114.29$75,317.1166,901View SEC Filing Icon  
5/31/2024Sell652$119.24$77,744.4867,560View SEC Filing Icon  
4/30/2024Sell629$126.25$79,411.2568,212View SEC Filing Icon  
3/28/2024Sell2,624$140.04$367,464.9668,682View SEC Filing Icon  
12/1/2023Sell3,612$114.56$413,790.7258,394View SEC Filing Icon  
4/3/2023Sell3,612$114.48$413,501.7661,870View SEC Filing Icon  
See Full Table

Michael Jon Brown Buying and Selling Activity at DexCom

This chart shows Michael Jon Brown's buying and selling at DexCom by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DexCom Company Overview

DexCom logo
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $74.46
Low: $74.14
High: $75.76

50 Day Range

MA: $70.43
Low: $65.68
High: $76.27

2 Week Range

Now: $74.46
Low: $62.34
High: $142.00

Volume

3,165,666 shs

Average Volume

3,924,561 shs

Market Capitalization

$29.08 billion

P/E Ratio

44.59

Dividend Yield

N/A

Beta

1.17